539871 Share Price Performance
₹0
-330.22 (-100.00%)
Price ₹0
Fair Value₹603.00
Share Pricen/a
Narrative Update • Jun 19
Thyrocare Technologies Limited Stock Price
- 1 Narratives written by author
- 0 Comments on narratives written by author
- 6 Fair Values set on narratives written by author
539871 Community Narratives
AN
Fair Value
·Fair Value ₹603 7.4% undervalued intrinsic discount
Upcoming Bonus Shares And Dividend Proposal Will Drive Shareholder Value
0users have liked this narrative
0users have commented on this narrative
4users have followed this narrative
Upcoming Bonus Shares And Dividend Proposal Will Drive Shareholder Value
Thyrocare is pushing into smaller cities and adding new kinds of tests, which could bring in more customers and improve profits as its network scales. But its growth depends heavily on partners and franchises that can walk away, and fast-changing home testing and digital health trends could chip away at demand.Read more
AN
₹603
7.4% undervalued intrinsic discount
Fair Value
Revenue
17.1% p.a.
Profit Margin
22.24%
Future PE
46.14x
Price in 2029
₹853.68
Trending Discussion
Recently Updated Narratives
AN
539871: Expanded Healthcare Objects Clause And New Auditors Will Support Bullish View
Fair Value: ₹603 7.4% undervalued intrinsic discount
4 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Flawless balance sheet with solid track record and pays a dividend.
1 Risk
2 Rewards
Thyrocare Technologies Limited Key Details
About 539871
- Founded
- 1996
- Employees
- 1906
- CEO
- WebsiteView website
Thyrocare Technologies Limited provides diagnostic testing services to patients, laboratories, and hospitals in India. It operates through three segments: Diagnostic Testing Services, Imaging Services, and Others. The Diagnostic Testing Services segment engages in the selling of consumables used for collection, and promotion of pathology. The Imaging Services segment sells radio-pharmaceutical and consumables for reporting. The Others segment engages in the sale of glucometer and glucostrips under the brand name sugarscan. The company offers diagnostic and pathological services. The company was founded in 1996 and is based in Navi Mumbai, India. Thyrocare Technologies Limited is a subsidiary of Docon Technologies Private Limited.
